Vera Therapeutics, Inc. (VERA) Misses Q3 EPS by 21c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $35.66 +4.18%
EPS Growth %: -27.8%
Financial Fact:
NET INTEREST INCOME: 17.73K
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -27.8%
Financial Fact:
NET INTEREST INCOME: 17.73K
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q3 EPS of ($0.91), $0.21 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Tilly's, Inc. (TLYS) Tops Q2 EPS by 10c, Beats on Revenue
- Broadcom (AVGO) Tops Q3 EPS by 11c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
